Results 201 to 210 of about 184,386 (363)
Ventricular Arrhythmia in the Left Ventricular Assist Device Patient
Peter Hanna, MD, Jason S. Bradfield, MD
doaj
In Vitro Characterization of a Magnetically Suspended Continuous Flow Ventricular Assist Device
Hee Chan Kim+5 more
openalex +1 more source
Abstract Aims Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy Clinic may improve outcomes and prevent progression to advanced heart failure.
Chandu Sadasivan+12 more
wiley +1 more source
Pregnancy with a Left Ventricular Assist Device: A Narrative Review. [PDF]
Abraham MS+6 more
europepmc +1 more source
Numeric Modeling of the Cardiovascular System with a Left Ventricular Assist Device
Jianhua Zhou+5 more
openalex +1 more source
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal+17 more
wiley +1 more source
Why Is Social Reintegration Support for Patients With Left Ventricular Assist Device Necessary? [PDF]
Inoue T+6 more
europepmc +1 more source
Cracked Acrylic Ventricular Assist Devices after Using a Doppler Stethoscope and Ultrasound Transmission Gel to Predict Impending Pump Failure: A Case Report [PDF]
Verna E. Nelson
openalex +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is defined by heart failure (HF) with a left ventricular ejection fraction (LVEF) of at least 50%. HFpEF has a complex and heterogeneous pathophysiology with multiple co‐morbidities contributing to its presentation. Establishing the diagnosis of HFpEF can be challenging.
Roy Rasalam+4 more
wiley +1 more source